These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 1905069
1. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein. Binnema DJ, Dooijewaard G, Turion PN. Thromb Haemost; 1991 Feb 12; 65(2):144-8. PubMed ID: 1905069 [Abstract] [Full Text] [Related]
2. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate. Tsuda H, Miyata T, Iwanaga S, Yamamoto T. Thromb Haemost; 1992 Apr 02; 67(4):440-4. PubMed ID: 1631792 [Abstract] [Full Text] [Related]
3. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator. Kluft C, Trumpi-Kalshoven MM, Jie AF, Veldhuyzen-Stolk EC. Thromb Haemost; 1979 Jun 30; 41(4):756-73. PubMed ID: 483248 [Abstract] [Full Text] [Related]
4. The contact-system dependent plasminogen activator from human plasma: identification and characterization. Binnema DJ, Dooijewaard G, van Iersel JJ, Turion PN, Kluft C. Thromb Haemost; 1990 Nov 30; 64(3):390-7. PubMed ID: 2128968 [Abstract] [Full Text] [Related]
14. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa). Alving BM, Tankersley DL, Mason BL. J Lab Clin Med; 1983 Feb 30; 101(2):226-41. PubMed ID: 6549773 [Abstract] [Full Text] [Related]
15. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator. Lijnen HR, Nelles L, Van Hoef B, De Cock F, Collen D. Thromb Haemost; 1988 Oct 31; 60(2):247-50. PubMed ID: 3146141 [Abstract] [Full Text] [Related]
16. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function. Wojta J, Binder BR, Huber K, Hoover RL. Thromb Haemost; 1989 Apr 25; 61(2):289-93. PubMed ID: 2501899 [Abstract] [Full Text] [Related]